Filing Signals

Source: SEC EDGAR Compiled 2026-09-14 08:28 UTC All 21 checks passing

← All events

QUANTUM CORP /DE/

CIK 709283 QMCO·Manufacturing · All EDGAR filings ↗

Late filing elevated Filing comparison

QUANTUM CORP /DE/ told the SEC it could not file its annual report on time

Does not expect a significant change in results. Filed 14 days before the statutory due date.

Quantum Corporation (the “Company”) is unable to file its Annual Report on Form 10-K (the “Form 10-K”) for the fiscal year ended March 31, 2026 (“Fiscal 2026”) by June 15, 2026, the original due date for such filing, without unreasonable effort or expense due to the circumstances described below. In June 2026, the Company completed a series of transactions. The preparation, execution, and financial reporting for these transactions required substantial and sustained focus from the Company’s senior management during the period leading up to the original filing due date. As a result, the Company is working with its independent registered public accounting firm to complete the audit of the…
Evidence
Anticipates significant change
No
Days past due date
-14
Other periodic reports filed
Yes
Routine
No
Severity
elevated
Source
Form 12b-25 (notification of late filing)
Stated reason
Quantum Corporation (the “Company”) is unable to file its Annual Report on Form 10-K (the “Form 10-K”) for the fiscal year ended March 31, 2026 (“Fiscal 2026”) by June 15, 2026, the original due date for such filing, without unreasonable effort or expense due to the circumstances described below. In June 2026, the Company completed a series of transactions. The preparation, execution, and financial reporting for these transactions required substantial and sustained focus from the Company’s senior management during the period leading up to the original filing due date. As a result, the Company is working with its independent registered public accounting firm to complete the audit of the…
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.